JNJ

237.69

+1.42%↑

UNH

268.72

-2.61%↓

TMO

542.22

-4.11%↓

ABT

109.21

+1.05%↑

ISRG

476.27

-0.36%↓

JNJ

237.69

+1.42%↑

UNH

268.72

-2.61%↓

TMO

542.22

-4.11%↓

ABT

109.21

+1.05%↑

ISRG

476.27

-0.36%↓

JNJ

237.69

+1.42%↑

UNH

268.72

-2.61%↓

TMO

542.22

-4.11%↓

ABT

109.21

+1.05%↑

ISRG

476.27

-0.36%↓

JNJ

237.69

+1.42%↑

UNH

268.72

-2.61%↓

TMO

542.22

-4.11%↓

ABT

109.21

+1.05%↑

ISRG

476.27

-0.36%↓

JNJ

237.69

+1.42%↑

UNH

268.72

-2.61%↓

TMO

542.22

-4.11%↓

ABT

109.21

+1.05%↑

ISRG

476.27

-0.36%↓

Search

Prometheus Biosciences Inc

Aperta

0

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

Massimo

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+0.04% upside

Prometheus Biosciences Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 feb 2026, 00:00 UTC

Azioni calde

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 feb 2026, 22:55 UTC

Utili

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 feb 2026, 21:44 UTC

Utili

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 feb 2026, 21:39 UTC

Utili

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 feb 2026, 00:00 UTC

Utili

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 feb 2026, 00:00 UTC

Utili

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 feb 2026, 23:46 UTC

Discorsi di Mercato

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 feb 2026, 23:45 UTC

Utili

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 feb 2026, 23:32 UTC

Discorsi di Mercato

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 feb 2026, 22:59 UTC

Acquisizioni, Fusioni, Takeovers

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 feb 2026, 22:30 UTC

Utili

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 feb 2026, 22:30 UTC

Utili

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 feb 2026, 22:21 UTC

Utili

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 feb 2026, 22:17 UTC

Discorsi di Mercato

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 feb 2026, 22:15 UTC

Discorsi di Mercato

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 feb 2026, 22:00 UTC

Discorsi di Mercato

ESG Roundup: Market Talk

4 feb 2026, 21:53 UTC

Utili

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 feb 2026, 21:51 UTC

Utili

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 feb 2026, 21:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

4 feb 2026, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Financial Services Roundup: Market Talk

4 feb 2026, 21:50 UTC

Discorsi di Mercato
Utili

Auto & Transport Roundup: Market Talk

4 feb 2026, 21:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

4 feb 2026, 21:45 UTC

Utili

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 feb 2026, 21:44 UTC

Utili

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 feb 2026, 21:43 UTC

Utili

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 feb 2026, 21:41 UTC

Utili

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 feb 2026, 21:36 UTC

Discorsi di Mercato

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 feb 2026, 21:30 UTC

Utili

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 feb 2026, 21:30 UTC

Utili

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 feb 2026, 21:30 UTC

Utili

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Confronto tra pari

Modifica del prezzo

Prometheus Biosciences Inc Previsione

Obiettivo di Prezzo

By TipRanks

0.04% in crescita

Previsioni per 12 mesi

Media 200 USD  0.04%

Alto 200 USD

Basso 200 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Prometheus Biosciences Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

7 ratings

0

Acquista

7

Mantieni

0

Vendi

Notizie finanziarie

$

help-icon Live chat